VB Spine Acquires Stryker’s Spine Division: A New Global MedTech Powerhouse Emerges
A Strategic Move That Will Change Spine Care Forever!
Stryker has officially announced the sale of its U.S. spinal implants business to Viscogliosi Brothers (VB), paving the way for a new, specialized spine company: VB Spine. More than another important MedTech acquisition, it’s a game-changing strategic move reshaping the global spine industry on all continents.
If you’re a MedTech stakeholder, you need to understand:
- Why will it change the Spine Market?
- How does VB Spine fit into a bigger, long-term strategy?
- What does this mean for the future of spine surgery, robotics, and motion preservation?
Why This Move Will Reshape the Spine Market
This deal isn’t just about Stryker selling a business unit. It’s part of a much more significant strategic shift in the industry that directly affects surgeons, hospitals, manufacturers, and patients worldwide.
As a new, specialized player in Spine, VB Spine is all about focus and innovation, and it is ready to challenge the majors with innovative strategies coupled with the latest technological solutions.
Robotics & AI Take Center Stage: With exclusive access to Stryker’s Mako Spine and Copilot technologies, VB Spine is now positioned to drive the robotic revolution in spine surgery.
Market Consolidation & Investment: With Stryker out, Medtronic, Depuy Synthes, Globus, and Zimmer Biomet may respond, either through new acquisitions, aggressive market expansions, or partnerships.
Better Clinical & Patient Outcomes: By combining robotics, minimally invasive solutions, and non-surgical technologies, VB Spine could push spine surgery into a new era of innovation and precision.
The Bigger Picture: The Viscogliosi Strategy in Spine
The Viscogliosi Brothers (VB) are executing a long-term, highly strategic vision for the future of spine care. Their track record in the spine industry shows a clear and methodical strategy; here are a few examples:
- Centinel Spine – World leader in disc replacement. VB has long championed motion preservation, a key trend in modern spine surgery.
- Companion Spine – Advancing minimally invasive spine solutions and motion preservation.
- Woven Orthopedic Technologies – Designing innovative orthopedic solutions for compromised bone scenarios.
- Spine BioPharma – Developing non-surgical, non-opioid pain management solutions.
The Vision Is Clear
With VB Spine, the Viscogliosi Brothers are not just selling “products” they are building a next-generation spine ecosystem. The Stryker Spine acquisition This is more than just a deal. It’s a deliberate step toward the future of spine care.
Understanding the Brotherhood Behind VB Spine
At the core of this acquisition is not just a business strategy; it’s a deeply personal mission driven by the Viscogliosi Brothers’ relentless commitment to improving lives.
To truly understand the passion, resilience, and vision that fuel their work, you need to go beyond the headlines. Marc Viscogliosi’s story is one of overcoming challenges, embracing innovation, and constantly pushing boundaries. His journey from childhood to leading groundbreaking advancements in MedTech is a testament to the mindset that drives the brothers and VB Spine forward. If you want to feel the passion behind this acquisition, take a moment to read Marc’s heartfelt story.
Click here to read “The Audacity to Care” by Marc Viscogliosi.